Vikram M. Narayan, MD (@vikramnarayan) 's Twitter Profile
Vikram M. Narayan, MD

@vikramnarayan

Urologic cancer surgeon @emory_urology & @WinshipAtEmory & Director of Urologic Oncology @GradyHealth. (I post and check this infrequently; find me on Bluesky)

ID: 1059456860

linkhttps://bsky.app/profile/vikramnarayan.bsky.social calendar_today04-01-2013 03:41:53

705 Tweet

1,1K Followers

858 Following

Haydn Kissick (@haydnkissick) 's Twitter Profile Photo

Check out our latest paper “Differentiation fate of a stem-like CD4 T cell control immunity to cancer”, led by Maria Andrea Cardenas now live nature tinyurl.com/33d24k89 . This work examines how CD4 T cell differentiation dictates the outcome of the cancer response. Thread below

Emory Urologic Oncology (@emoryuroonc) 's Twitter Profile Photo

Ready to learn more about Emory’s YUO fellowship program? 📆 Mark your calendars and join us for a virtual open house on Thursday, January 16th from 7-8 PM EST via Zoom Reach out to us if you’re interested in joining for the link! Find us also on Bluesky

Candace Granberg, MD (@candacegranberg) 's Twitter Profile Photo

Loved hearing about physician informatics from Vikram M. Narayan, MD - exciting things on the horizon to help optimize our EMR use, ambient listening for clinic visits, and next-level VR/sim for surgical education. Minnesota Urological

Loved hearing about physician informatics from <a href="/VikramNarayan/">Vikram M. Narayan, MD</a> - exciting things on the horizon to help optimize our EMR use, ambient listening for clinic visits, and next-level VR/sim for surgical education.

<a href="/MNUrological/">Minnesota Urological</a>
Brian F. Chapin (@chapinmd) 's Twitter Profile Photo

“From Fellowship to faculty” UT fellow alumni presenting cases to the#UTCGW symposium. Proud of these fine docs and love the opening by Dan Shapiro, roasting all the faculty from MD Anderson Cancer Center #oncsurgery

“From Fellowship to faculty”
UT fellow alumni presenting cases to the#UTCGW symposium. 

Proud of these fine docs and love the opening by Dan Shapiro, roasting all the faculty from <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> 
#oncsurgery
Ryan Haumschild PharmD, MS, MBA, CPEL (@rxhaums) 's Twitter Profile Photo

In collaboration with our internal Urology department at Winship Cancer Institute of Emory University , we've introduced several groundbreaking therapies—immunotherapy, NK cell therapy, gene therapy, and more—with the goal of expanding patient access across multiple locations. Excited about the future!

In collaboration with our internal Urology department at <a href="/WinshipAtEmory/">Winship Cancer Institute of Emory University</a> , we've introduced several groundbreaking therapies—immunotherapy, NK cell therapy, gene therapy, and more—with the goal of expanding patient access across multiple locations. Excited about the future!
Abridge (@abridgehq) 's Twitter Profile Photo

🎥𝗔𝗯𝗿𝗶𝗱𝗴𝗲, 𝗔𝗽𝗽𝗹𝗲, 𝗮𝗻𝗱 𝗘𝗺𝗼𝗿𝘆: Transforming clinical workflows with the leading AI platform for medical conversations See how Abridge facilitates full integration with the EHR and healthcare workflows at Emory with user-friendly enterprise-grade technology in

🎥𝗔𝗯𝗿𝗶𝗱𝗴𝗲, 𝗔𝗽𝗽𝗹𝗲, 𝗮𝗻𝗱 𝗘𝗺𝗼𝗿𝘆: Transforming clinical workflows with the leading AI platform for medical conversations 

See how Abridge facilitates full integration with the EHR and healthcare workflows at Emory with user-friendly enterprise-grade technology in
UroToday.com (@urotoday) 's Twitter Profile Photo

Nadofaragene firadenovec for BCG-unresponsive CIS: Efficacy, durability, and practical considerations. Vikram M. Narayan, MD Emory Urology and Zach Klaassen Georgia Cancer Center discuss how this non-replicating adenovirus delivers interferon alfa-2b directly into bladder cells, providing

Anirudh Joshi (@anirrjoshi) 's Twitter Profile Photo

Excited to share our Valar Labs publication in European Urology validating Vesta Risk Stratify computational histology AI biomarkers to predict recurrence and progression in High Grade Ta Bladder Cancer. (1/5) Publication: authors.elsevier.com/c/1lFoD14kpm0h…

Excited to share our <a href="/valarlabs/">Valar Labs</a> publication in <a href="/EUplatinum/">European Urology</a> validating Vesta Risk Stratify computational histology AI biomarkers to predict recurrence and progression in High Grade Ta Bladder Cancer. (1/5)

Publication: authors.elsevier.com/c/1lFoD14kpm0h…
Valar Labs (@valarlabs) 's Twitter Profile Photo

We are pleased to share our new publication in European Urology validating Vesta Risk Stratify biomarkers for prediction of recurrence and progression in High Grade Ta Bladder Cancer. Press Release: businesswire.com/news/home/2025… Grateful to all the collaborators involved and